Efficacy of Sacubitril-Valsartan in Patients With Reduced Left Ventricular Ejection Fraction

Am J Cardiol. 2021 Aug 15:153:150-152. doi: 10.1016/j.amjcard.2021.05.033. Epub 2021 Jun 29.

Authors

Alexandros Briasoulis¹, Toshiki Kuno², Hiroki Ueyama²

Affiliations

¹ Division of Cardiovascular Medicine, Section of Heart failure and Transplantation, University of Iowa, Iowa; National Kapodistrian University of Athens Medical School, Athens, Greece. Electronic address: alexbriasoulis@gmail.com.
² Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York.

PMID: 34210504
DOI: 10.1016/j.amjcard.2021.05.033

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Aged
Aminobutyrates / therapeutic use*
Angiotensin Receptor Antagonists / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Biphenyl Compounds / therapeutic use*
Cardiovascular Diseases / mortality
Drug Combinations
Enalapril / therapeutic use
Enzyme Inhibitors / therapeutic use*
Female
Heart Failure / drug therapy*
Heart Failure / prevention & control
Hospitalization
Humans
Male
Middle Aged
Myocardial Infarction / drug therapy
Neprilysin / antagonists & inhibitors
Ramipril / therapeutic use
Severity of Illness Index
Stroke Volume*
Valsartan / therapeutic use*
Ventricular Dysfunction, Left / drug therapy*

Substances

Aminobutyrates
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Biphenyl Compounds
Drug Combinations
Enzyme Inhibitors
Enalapril
Valsartan
Neprilysin
Ramipril
sacubitril and valsartan sodium hydrate drug combination